Sort by
Refine Your Search
-
Listed
-
Category
-
Program
-
Field
-
the Middle East with the opening of a new office in Riyadh, Saudi Arabia. This exciting development will enhance our engagement in Saudi Arabia and support the country's Vision 2030 objectives, around Human
-
designed to strengthen the technological systems that underpin our research. The post holder will be accountable for strategy, engagement, vision, development and delivery of IT services in support of
-
About the Role You will contribute to the delivery of teaching, assessment, and curriculum development in Restorative Dentistry, working with a diverse and talented undergraduate cohort. The role
-
-Policy Platform is a £20m five-year LSHTM-led consortium, co-funded by the Foreign, Commonwealth and Development Office (FCDO) and Gates Foundation (GF). A global evidence platform accelerating actions
-
this cohort are around 40,000 University of London students who study programmes which are developed and delivered in partnership with our 17 federation members. The University of London is also home to
-
the product development and strategic scaling of the system's capabilities, translating organisational ambition into measurable customer and business outcomes including improved lead conversion, customer
-
strategic goals. The Business Systems Manager will collaborate with various departments and cross-functional teams to develop and manage strategies for the further development and exploitation of systems
-
will support our apprentices in developing the skills and behaviours needed to thrive in their apprenticeships – this will include leading tri-partite meetings with apprentices and their employers
-
at Undergraduate Laws is required to have an international focus to reflect the student body. As Module Convenor, you will be expected to provide academic leadership and development of the academic content for your
-
-led by Queen Mary University of London. PharosAI is set to revolutionise AI-powered cancer care, accelerating the development of breakthrough therapies, advancing clinical applications, and improving